The obtained outcomes present a strong indication of a strong positive correlation between PD-L1 expression and DDX3X, which signifies the potential of DDX3X as a reliable marker for diagnosis and prognosis and treatment response prediction in pancreatic cancer. The gene discussed is DDX3X; the disease is familial pancreatic carcinoma.